Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ITOS:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2025 493.80M
March 31, 2025 563.42M
December 31, 2024 590.29M
September 30, 2024 631.69M
June 30, 2024 663.87M
March 31, 2024 541.20M
December 31, 2023 575.23M
September 30, 2023 598.26M
June 30, 2023 623.53M
March 31, 2023 652.26M
December 31, 2022 663.33M
Date Value
September 30, 2022 634.20M
June 30, 2022 637.30M
March 31, 2022 626.38M
December 31, 2021 552.82M
September 30, 2021 372.04M
June 30, 2021 289.50M
March 31, 2021 312.61M
December 31, 2020 323.20M
September 30, 2020 335.63M
June 30, 2020 -47.92M
March 31, 2020 -38.53M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ZimVie, Inc. (DELISTED) 412.80M
Sarepta Therapeutics, Inc. 1.528B
Black Titan Corp. 1.555M
Solid Biosciences, Inc. 374.08M
Replimune Group, Inc. 105.64M

Shareholders Equity (Quarterly) Related Metrics